Total Funding
30
Total FundingSeries C raised
Growth Score in past quarter
pts
Heat Score 30 in past quarter
10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
707811
Proteolix is a biopharmaceutical company that conducts research, development, and commercialization of cancer and autoimmune medicines.
Acquired by 

Onyx Pharmaceuticals
- Raymond Deshaies: Founder
- Phil Whitcome: Founder
About the Company
Onyx Pharmaceuticals (NASDAQ: ONXX) is a biopharmaceutical company engaged in the development and commercialization of innovative therapies for improving the lives of people with cancer and other serious diseases.


